UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000023815
Receipt number R000027309
Scientific Title A Phase II study of combination chemotherapy including Bortezomib in pediatric patients with relapsed acute lymphoblastic leukemia (Investigator-initiated clinical trial)
Date of disclosure of the study information 2016/09/09
Last modified on 2021/03/31 10:53:28

No. Disposal Last modified on Item of update
1 Insert 2016/08/29 14:12:11
2 Update 2016/08/30 09:17:56 Institutions
Date of disclosure of the study information
3 Update 2016/09/09 14:45:20 Anticipated trial start date
4 Update 2016/09/09 14:46:00 Date of disclosure of the study information
5 Update 2016/09/23 11:26:32 Recruitment status
6 Update 2016/11/09 11:39:43 Last name of contact person
Last name of contact person
Name of person sending information
Name of person sending information
Institutions
7 Update 2016/11/16 10:53:50 Institutions
8 Update 2016/11/29 11:01:31 Institutions
9 Update 2017/01/23 12:09:02 Institutions
10 Update 2017/05/31 10:52:55 Condition
Condition
Narrative objectives1
Narrative objectives1
11 Update 2017/05/31 10:59:31 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
12 Update 2018/04/23 11:40:39 Key exclusion criteria
Key exclusion criteria
13 Update 2018/04/23 11:43:50 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
14 Update 2018/09/06 14:04:36 Institutions
15 Update 2020/03/18 14:26:13 Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
16 Update 2020/04/02 13:44:14 Recruitment status
17 Update 2021/03/31 10:53:28 Recruitment status